Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Immunoprecipitation01:20

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of the synthetic route to 5-hydroxymethyl tolterodine, a key synthetic intermediate of Toviaz, <i>via</i> an organic solvent-free Rh-catalyzed asymmetric 1,4-addition.

Organic & biomolecular chemistry·2026
Same author

Roles of TIF1β in Leukemic Stem Cell Through SETDB1-Dependent and Independent Mechanisms.

Cancer science·2026
Same author

Air-Stable 2,2'-Azobispyridine Radical-Boron Complexes and Their Near-Infrared Absorption Properties.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

[Dysfunction and premature aging of hematopoietic stem cells in Down syndrome].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same author

Sterilizable autoantigen immobilized column platform for broad-spectrum removal of pathogenic autoantibodies in autoimmune diseases.

Journal of bioscience and bioengineering·2025
Same author

Autoantibody spark response predicts treatment outcome in patients receiving chemoradiation followed by durvalumab therapy.

Scientific reports·2025

Related Experiment Video

Updated: Jul 19, 2026

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

20.9K

A Cysteine-Specific Cationization Strategy for Versatile Antibody Production against Intrinsically Disordered

Ryui Sakaguchi1, Ai Miyamoto1, Rikako Kutsuma1

  • 1Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan.

Bioconjugate Chemistry
|March 4, 2026
PubMed
Summary

This study introduces cysteine-specific cationization to stabilize and purify unstable autoantigens for accurate autoantibody detection. Control antibodies were developed, proving effective for diagnostic assay validation.

More Related Videos

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

6.1K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.6K

Related Experiment Videos

Last Updated: Jul 19, 2026

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

20.9K
Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

6.1K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.6K

Area of Science:

  • Biochemistry
  • Immunology
  • Protein Chemistry

Background:

  • Autoantigens, particularly those targeted in antitumor responses, often possess disordered regions, leading to instability and aggregation.
  • This instability complicates laboratory production, purification, and analysis of autoantigens.
  • Accurate autoantibody assays require stable antigens and well-validated positive control antibodies.

Purpose of the Study:

  • To develop a method for solubilizing and purifying unstable autoantigens.
  • To generate and characterize control antibodies for autoantibody array assays.
  • To validate a platform for producing antibodies against intrinsically disordered proteins.

Main Methods:

  • Cysteine-specific cationization was employed to solubilize and purify intrinsically disordered autoantigens.
  • Purified antigens were used in suspension Luminex bead array platforms for autoantibody assays.
  • Rabbits were immunized with cysteine-specific S-cationized antigens to generate control antibodies.

Main Results:

  • Cysteine-specific cationization successfully produced full-length, water-soluble, denatured antigens.
  • Generated control antibodies recognized linear epitopes and functioned effectively in autoantibody array assays.
  • These antibodies also bound to native, unmodified intracellular antigens, demonstrating broad utility.

Conclusions:

  • Cysteine-specific cationization is a versatile platform for managing unstable, disordered proteins for diagnostic antigen production.
  • The developed control antibodies are valuable reagents for autoantibody assay validation.
  • This approach facilitates antibody development against challenging intrinsically disordered proteins.